Abingworth LLP
- SEC CIK
- 0001397144
- Latest filing
- Feb 10, 2023
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 10, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 19
- 0 vs. Q3 2022
- Portfolio value
- $303.5M
- +$11.0M (+3.8%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| OBSVObsEva SA | COM | 87,999 | $12.8K | <0.1% | 00.0% | Unchanged | History |
| MTEMMolecular Templates, Inc. | COM | 200,000 | $66.0K | <0.1% | 00.0% | Unchanged | History |
| SYRESpyre Therapeutics, Inc. | COM | 240,500 | $108.2K | <0.1% | 00.0% | Unchanged | History |
| XCURExicure, Inc. | COM NEW | 281,636 | $323.9K | 0.1% | 00.0% | Unchanged | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 131,036 | $821.6K | 0.3% | 00.0% | Unchanged | History |
| PRTKParatek Pharmaceuticals, Inc. | COM | 1,041,131 | $1.95M | 0.6% | 00.0% | Unchanged | History |
| SPRBSpruce Biosciences, Inc. | COM | 1,792,518 | $1.97M | 0.6% | 00.0% | Unchanged | History |
| EFTReFFECTOR Therapeutics, Inc. | COM | 4,822,114 | $2.06M | 0.7% | 00.0% | Unchanged | History |
| NCNANuCana plc | SPONSORED ADR | 3,333,333 | $2.20M | 0.7% | 00.0% | Unchanged | History |
| SLNOSoleno Therapeutics Inc | COM | 1,201,506 | $2.38M | 0.8% | 00.0% | Unchanged | History |
| JSPRJasper Therapeutics, Inc. | COM | 5,628,558 | $2.72M | 0.9% | 00.0% | Unchanged | History |
| OKUROnKure Therapeutics, Inc. | COM | 2,073,957 | $4.83M | 1.6% | 00.0% | Unchanged | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,435,106 | $16.1M | 5.3% | 00.0% | Unchanged | History |
| ACETAdicet Bio, Inc. | COM | 2,115,385 | $18.9M | 6.2% | 00.0% | Unchanged | History |
| HLVXHilleVax, Inc. | COM | 1,838,486 | $30.8M | 10.1% | 00.0% | Unchanged | History |
| VERAVera Therapeutics, Inc. | CL A | 2,960,231 | $57.3M | 18.9% | 00.0% | Unchanged | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 2,457,500 | $64.2M | 21.2% | 00.0% | Unchanged | History |
| PCVXVaxcyte, Inc. | COM | 2,019,057 | $96.8M | 31.9% | −2,149,661−51.6% | Reduced | History |
| SIENProject Sage Oldco, Inc. | COM | 1,673,589 | – | – | 00.0% | Unchanged | History |